Member Info for Dustbin101

Skin barrier repair could be an even larger market , ( over time ) , than Zenakine.

Https://www.skinbiotherapeutics.com/wp-content/uploads/2025/04/Croda-Beauty-Actives_Technical-seminar-theatre-4_8th.pdf

Page 24 :

These massive numbers will attract the big pharma players to SBTX .

Why Organic Private Label Products Are Taking the Lead

There’s been a noticeable boom in demand for private label organic skin care, and it’s no coincidence. As more people prioritise wellness and sustainability in all aspects of life, their skincare routines have followed suit. Organic products, often free of synthetic chemicals and harmful additives, provide peace of mind along with performance.

This surge in interest has pushed manufacturers to raise the bar. A personal care manufacturer is now expected to source ethically, develop clean formulations, and provide proof of quality. In turn, retailers benefit from offering high-quality organic lines that consumers can trust.

“”Never going to make inroads into Retinol and Matrixyl.**

All the large players and perhaps 98% of the smaller players are going Bio and sustainable by 2030.

Croda is delivering what those cosmetics companies , ( and consumers ,demand today ).

Go look up Retinol, and see what else can challenge it , ( within the green space ), cost effectively today, in volume , from a trusted partner, with sleep benefits and a lot more thrown in.

Also take a look at the long list of cosmetics brands that failed to innervate , and have gone bust.

No other product has been produced, ( in a stable format), to date.

Both Matrixyl (30 years old ), and Retinol, ( fail on all counts, when used in low concentrations as the EU is enforcing )

You’re looking at a blockbuster.

Croda knows this, and hence the reason they are so positive on Zenakine.

The amount Croda can sell with 12,000 clients and the fact Zenakine can be used in just about any cosmetic ensures this.

SBTX at £43M requires tiny profits to justify its market cap today.

First neurocosmetic active with clinical instrumental measures on sleep quality and duration benefits.

Sent to those registered with Croda, for news.

New product launch: back in sync with yourself with Zenakine™

Oleric;

I think you will find the cosmetic industry has already jumped on board.

Croda intend to grab huge market share replacing Retinol , with a better, greener , sustainable and bio Zenakine.

( that also helps you gain quality sleep, and makes you feel good, to boot .!!! ).

Zenakine has blockbuster written all over it

Well guys , not long to wait for news.

Best guess is the NDA will be lifted on 8th June , ( we have been told it’s prior to the 30th of June. ).

It’s pointless to use any marketing spend till Zenakine hits the shelf.

In any event the spend will not be by Croda.

It will be by the cosmetics companies.

It’s the recurring income that makes SBTX so attractive.

We really appreciate your interest in our latest neurocosmetic active.

Zenakine is a raw material (as are all of Croda’s ingredients) which needs to be formulated into a finished skin care product, such as a serum or cream at the recommended usage level, and must then be subjected to the necessary safety, stability and efficacy testing. It is not suitable, or safe, for consumer use as supplied. Regretfully for those reasons we’re unable to supply samples for personal use, apologies.

Kind regards,

Croda UK Enquiries Team

Croda Europe Ltd

Cowick Hall, Snaith

That’s odd.

Since Croda is not sending out finished product as samples .!

NIVEA FACES CLASS ACTION OVER ‘NATURAL’ CLAIMS IN SKINCARE RANGE

Posted by Global Cosmetics News | May 13, 2025 | Ingredients, North America, Regulatory |

Nivea Faces Class Action Over ‘Natural’ Claims in Skincare Range

THE WHAT? Beiersdorf Inc., the parent company of Nivea, is facing a proposed class action lawsuit filed in a California federal court. The suit alleges that the company misled consumers by falsely advertising certain skincare lines—specifically Nourish by Nature and Naturally Good—as containing a specific percentage of “natural origin” or “naturally derived” ingredients.

THE DETAILS Filed on April 25, the lawsuit claims that five plaintiffs purchased Nivea products labeled with statements such as “X% Natural Origin Ingredients,” only to discover the formulas were composed largely of synthetic substances. The complaint argues that Beiersdorf used the ISO 16128 standard—a non-regulatory, industry-developed guideline not intended for marketing purposes—to justify its ingredient claims. The plaintiffs allege that this standard allowed the company to reclassify synthetic ingredients as “naturally derived,” misleading consumers who were trying to make environmentally conscious and skin-sensitive purchases. They seek class action certification, damages, and a jury trial, and aim to represent all California consumers who bought the products between April 25, 2021, and the present.

THE WHY? This legal challenge underscores a broader reckoning within the cosmetics and personal care industry over the transparency and definition of so-called “natural” claims. As consumer demand for clean and natural products grows, so too does scrutiny of how these terms are substantiated—or manipulated—by brands. The outcome of this case could set an important precedent for the use of voluntary standards like ISO 16128 in marketing, and may drive stricter regulation of natural-origin claims across the U.S. beauty sector

No BAZZ, however, if he deliveries on those items on my list , you will be the first to know. !!!!

Now, I ask myself what would Mr Ashman like to do over the next few weeks.

Well, if I was him, I would attempt to clear the NDA , seal a deal or two, get the broker to print some research, and tell the long term detractors on this BB , to run and jump.!!

LOL

When these events occur in any stock , it provides an opportunity for others to buy the shares, in the knowledge the previous owners, have not based their sales on the companies prospects .

Both Manchester uni and OPTI have held shares in SBTX for years .

Both require cash , to keep going, in their present form.

Both have had no access to the Croda NDA.

Both had reasons for selling that are totally unrelated to SBTX future prospects .

** Directors should be buying to settle investors nerves.**

What absolute rubbish.

Mr Ashman would be silly to buy a single share, when like me , he knows he can cash in his options at 80p and a quid.

He unlike your good self knows the business , and its growth rate to come.

You need constant reassurance just like a child.

parsons 4

spot on, and that’s from an accountant .

when i first invest in a very low cap company that can ten bag plus, i attend the next agm.

few investors show up , and the ones that do are all old , mostly men , and full of advice and distain for the directors.

how many times has this line been spat out to the directors, in the room

‘’you can’t run a **** up in a brewery ‘’

those same type of shareholders all over this bb.

this week, the blame game, for some reason, is being pointed at mr ashman, because of comments by opti who have been selling down sbtx shares repeatedly for years, and years. !!!!

it’s profits that drive share prices , and its profits that will drive the sbtx share price.

the best time to buy any share is when you can, without pushing up the share price , so you do not keep paying an ever higher price.

the richest man in the world buys and holds and takes zero notice of the day to day share price movements of his stocks .

have the loons here, ever thought why .??

Incorrect.

Returns ( unadjusted) of 27% compound over 20 years within my portfolio proves that buying super growth stocks before the crowd, and after extensive research, works.

Why would anyone look back here 5 years when share returns are always about the future. ?

However it does explain a great deal about your trading / investment style .

Good luck with that

Have you not noticed since last summer each time the share drifts downwards, it has gone on , to hit a new high.

Clearly not. .!!!